Table 2. Point-of-care strip-based devices that provide qualitative output and commercially available devices.
Application | Sample type | Detection principles | Stage | Setting | Currently available commercial devices |
---|---|---|---|---|---|
SARS-CoV-2 detection (viral RNA) | NP swab OP swab Saliva |
Immunochromatography/lateral flow immunoassay PCR |
Any stage of presentation to the healthcare provider | Inpatient and outpatient | SugenTech Respi-Strip |
Viral antigen detection (N/S antigens, spike receptor binding domain) | Serum | Standard sandwich ELISA | Any stage of presentation to the healthcare provider | Inpatient and outpatient | RayBiotech |
NP: Nasopharyngeal; OP: Oropharyngeal.